STAT Plus: A long-awaited report on orphan drugs in Europe suggests incentives to pharma need change
ADOBE
“The regulations have not adequately managed to support development in areas where the need for medicines is greatest," a European Commission report finds.
.png)
No hay comentarios:
Publicar un comentario